Research ArticleExperimental Studies

Interaction between Doxorubicin and the Resistance Modifier Stilbene on Multidrug Resistant Mouse Lymphoma and Human Breast Cancer Cells

MARIA-JOSÉ U. FERREIRA, NOÉLIA DUARTE, NORA GYÉMÁNT, RITA RADICS, GEORGY CHEREPNEV, ANDRAS VARGA and JOSEPH MOLNÁR
Anticancer Research September 2006, 26 (5A) 3541-3546;

Article Information

vol. 26 no. 5A 3541-3546
PMID 
17094479
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received March 15, 2006
  • Accepted July 7, 2006
  • Published online September 1, 2006.
Copyright & Usage 
Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. MARIA-JOSÉ U. FERREIRA1,
  2. NOÉLIA DUARTE1,
  3. NORA GYÉMÁNT2,
  4. RITA RADICS2,
  5. GEORGY CHEREPNEV3,
  6. ANDRAS VARGA4 and
  7. JOSEPH MOLNÁR2
  1. 1CECF, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
  2. 2Department of Medical Microbiology, University of Szeged, Szeged, Hungary
  3. 3Department of Medical Immunology (Charité), Humboldt University, Berlin, Germany
  4. 4Department of Molecular Parasitology, Humboldt University, Berlin, Germany
  1. Correspondence to: Prof. Joseph Molnár, Department of Medical Microbiology and Immunobiology, University of Szeged, H-6720, Szeged, Hungary. Fax: +36 62 545-113, e-mail: molnarj{at}comser.szote.u-szeged.hu

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Interaction between Doxorubicin and the Resistance Modifier Stilbene on Multidrug Resistant Mouse Lymphoma and Human Breast Cancer Cells
MARIA-JOSÉ U. FERREIRA, NOÉLIA DUARTE, NORA GYÉMÁNT, RITA RADICS, GEORGY CHEREPNEV, ANDRAS VARGA, JOSEPH MOLNÁR
Anticancer Research Sep 2006, 26 (5A) 3541-3546;
Twitter logo Facebook logo Mendeley logo

Jump to section